Drug Pipeline

NKTR-255 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05632809 REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE) Lung Cancer Recruiting
NCT05327530 A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in… Locally Advanced or Metastatic Urothelial Carcinoma Active, Not Recruiting
Phase 1
NCT05359211 NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or… Recurrent Diffuse Large B-Cell Lymphoma Active, Not Recruiting
Sponsors Running NKTR-255 Trials
EMD Serono Research & Development Institute, Inc. (1) Fred Hutchinson Cancer Center (1) M.D. Anderson Cancer Center (1)
Disease Areas
Bladder Cancer (1) Non-Hodgkin Lymphoma (1) DLBCL (1) Follicular Lymphoma (1) Lung Cancer (1)
Get alerts when NKTR-255 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free